Eltek Ltd.
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Exhibit 99.1
Press Release
Eltek Ltd. Reports
Third-Quarter 2026 Results
Petach Tikva, Israel (November 17, 2026) Eltek
Ltd. (NASDAQ: ELTK), a leading global manufacturer of high-quality printed circuit boards, today announced its financial results
for the quarter ended September 30, 2026.
Third Quarter 2026 Highlights
| § | Revenues were $12.0 million |
| § | Operating loss was $1.6 million |
| § | Net loss was $1.2 million, or $0.17 per fully diluted
share |
| § | Net cash provided by operating activities amounted
to $0.04 million. |
| § | $10.4 million in cash, cash equivalents and short-term
bank deposits and no outstanding debt as of September 30, 2026. |
Ron Freund, Chief Executive Officer, stated:
“Our third-quarter 2026 results reflect
continued progress in our operational improvement initiatives, with a reduction in the Company's losses compared to the first two quarters
of 2026.
During the quarter, we completed the installation
of our 39-meter first plating line. Initial results from the trials conducted to date indicate significant improvements in both product
quality and operational efficiency. We expect to complete the remaining optimization and validation processes over the coming months and
anticipate beginning qualification processes with key customers in early 2027.
We continue to experience sustained demand for
our products, supported by ongoing customer activity and new business opportunities. This positive momentum has contributed to an increase
in our order backlog for the remainder of 2026 and into 2027.
In parallel, we have implemented tighter production
planning and order management practices, with the objective of better aligning production capacity and schedules with customer-requested
delivery dates, while maintaining operational discipline and improving execution.
We remain focused on executing our operational
improvement plan, strengthening manufacturing stability, improving production efficiency, and enhancing customer satisfaction through
transparency, open communication and a continued commitment to meeting our customers' expectations. These efforts are aimed at positioning
Eltek to better capitalize on market demand and future growth opportunities."
Third Quarter 2026 GAAP Financial Results
Revenues for the third quarter of 2026
were $12.0 million compared to $13.3 million in the third quarter of 2025.
Gross profit for the third quarter of 2026
was $0.2 million (2% of revenues) compared to gross profit of $1.6 million (12% of revenues) in the third quarter of 2025.
Operating loss for the third quarter of
2026 was $1.6 million compared to operating profit of $0.05 million in the third quarter of 2025.
Financial income for the third quarter
of 2026 was $0.3 million compared to financial expenses of $0.3 million in the third quarter of 2025. Financial income primarily resulted
from the erosion of the NIS against the U.S. Dollar.
Net loss for the third quarter of 2026
was $1.2 million, or $0.17 per fully diluted share, compared to a net loss of $0.2 million, or $0.03 per fully diluted share, in the third
quarter of 2025.
As of September 30, 2026, we had $10.4 million
in cash, cash equivalents and short-term bank deposits and no outstanding debt.
Third Quarter 2026 Non-GAAP Financial Results
EBITDA loss for the third quarter of 2026
was $1.0 million compared to EBITDA of $0.6 million in the third quarter of 2025.
Nine Months Ended September 30, 2026 GAAP Financial
Results
Revenues for the first nine months of 2026
were $34.0 million compared to $38.6 million in the first nine months of 2025.
Gross loss for the first nine months of
2026 was $2.6 million compared to gross profit of $6.8 million (18% of revenues) in the first nine months of 2025.
Operating loss for the first nine months
of 2026 was $7.4 million compared to operating profit of $2.2 million in the first nine months of 2025.
Financial expenses for the first nine months
of 2026 were $0.5 million compared to $0.8 million in the first nine months of 2025. Financial expenses primarily resulted from the erosion
of the U.S. Dollar against the NIS.
Net loss for the first nine months of 2026
was $6.8 million, or $1.01 per fully diluted share, compared to net profit of $1.1 million, or $0.17 per fully diluted share, in the first
nine months of 2025.
Nine Months Ended September 30, 2026 Non-GAAP
Financial Results
EBITDA loss for the first nine months of
2026 was $5.6 million compared to EBITDA of $3.8 million in the first nine months of 2025.
About our Non-GAAP Financial Information
The Company reports financial results in accordance
with U.S. GAAP and herein provides EBITDA, a non-GAAP measure. This non-GAAP measure is not in accordance with, nor is it a substitute
for, GAAP measures. This non-GAAP measure is intended to supplement the Company’s presentation of its financial results that are
prepared in accordance with GAAP. The Company uses the non-GAAP measure presented to evaluate and manage the Company’s operations
internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation
between the Company's results on a GAAP and non-GAAP basis is provided in a table below.
Conference Call
Today, Tuesday, November 17, 2026, at 8:30am Eastern
Time (15:30pm Israel Time, 5:30am Pacific Time), Eltek will conduct a conference call to discuss the results. The call will feature remarks
by Ron Freund, Chief Executive Officer.
To participate, please call the following teleconference
numbers. Please allow for additional time to connect prior to the call:
| United States: |
1-866-860-9642 |
| Israel: |
03-918-0691 |
| International: |
+972-3-918-0691 |
To Access a Replay of the Call
A replay of the call will be available for 30
days on the Investor Info section on Eltek’s corporate website at http://www.nisteceltek.com approximately 24 hours after
the conference call is completed.
About Eltek
Eltek – "Innovation Across the Board"
– is a leading Israeli manufacturer of advanced printed circuit boards (PCBs), serving customers worldwide in demanding, technology-driven
industries. Founded in 1970, the Company specializes in the design and manufacture of complex, high-reliability PCBs, including HDI, multilayer,
rigid-flex and flexible boards, for mission-critical applications. Eltek serves leading customers in the defense, aerospace, medical and
other advanced industries across Israel, North America, Europe and Asia. The Company combines advanced manufacturing capabilities, engineering
expertise and internationally recognized quality standards, including AS9100D and NADCAP Electronics, to deliver high-performance solutions
where quality and reliability are essential. Eltek is ITAR compliant.
Headquartered in Israel, Eltek operates advanced
manufacturing and R&D facilities in Israel, a marketing subsidiary in North America and an international network of sales representatives
and distributors. For more information, visit Eltek's web site at www.nisteceltek.com
Forward Looking Statement
Some of the statements included in this press
release may be forward-looking statements that involve a number of risks and uncertainties including, but not limited to expected results
in future quarters, changes in general economic, market and business conditions, the impact of currency movements between the US Dollar
exchange rate against the Israeli Shekel, risks in product and technology development and rapid technological change, product demand,
the impact of competitive products and pricing, the sales cycle, risks associated with Eltek’s international operations and its
location in Israel, including those arising from regional military conflicts and geopolitical instability, and other risk factors detailed
in the Company’s Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission. Any forward-looking
statements set forth in this press release speak only as of the date of this press release. The information found on our website is not
incorporated by reference into this press release and is included for reference purposes only.
Investor Contact
Ron Freund
Chief Financial Officer
Investor-Contact@nisteceltek.com
+972-3-939-5023
(Tables follow)
| Eltek Ltd. |
| Consolidated Statements of Income |
| U.S dollars in thousands (except per share data) |
| | |
Three months ended | | |
Nine months ended | |
| | |
September 30, | | |
September 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
| | |
| | |
| |
| Revenues | |
| 12,019 | | |
| 13,267 | | |
| 33,989 | | |
| 38,552 | |
| Costs of revenues | |
| (11,789 | ) | |
| (11,671 | ) | |
| (36,575 | ) | |
| (31,725 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Gross profit (loss) | |
| 230 | | |
| 1,596 | | |
| (2,586 | ) | |
| 6,827 | |
| | |
| | | |
| | | |
| | | |
| | |
| Research and development expenses, net | |
| - | | |
| - | | |
| - | | |
| (50 | ) |
| Selling, general and administrative expenses | |
| (1,854 | ) | |
| (1,546 | ) | |
| (4,851 | ) | |
| (4,546 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Operating income (loss) | |
| (1,624 | ) | |
| 50 | | |
| (7,437 | ) | |
| 2,231 | |
| | |
| | | |
| | | |
| | | |
| | |
| Financial income (expenses), net | |
| 295 | | |
| (287 | ) | |
| (497 | ) | |
| (795 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Income (loss) before income tax | |
| (1,329 | ) | |
| (237 | ) | |
| (7,934 | ) | |
| 1,436 | |
| | |
| | | |
| | | |
| | | |
| | |
| Income tax expenses (tax benefit) | |
| (172 | ) | |
| (6 | ) | |
| (1,180 | ) | |
| 300 | |
| | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) | |
| (1,157 | ) | |
| (231 | ) | |
| (6,754 | ) | |
| 1,136 | |
| | |
| | | |
| | | |
| | | |
| | |
| Earnings per share: | |
| | | |
| | | |
| | | |
| | |
| Basic net income (loss) per ordinary share | |
| (0.17 | ) | |
| (0.03 | ) | |
| (1.01 | ) | |
| 0.17 | |
| | |
| | | |
| | | |
| | | |
| | |
| Diluted net income (loss) per ordinary share | |
| (0.17 | ) | |
| (0.03 | ) | |
| (1.01 | ) | |
| 0.17 | |
| | |
| | | |
| | | |
| | | |
| | |
| Weighted average number of ordinary shares used to compute | |
| | | |
| | | |
| | | |
| | |
| basic net income (loss) per ordinary share (in thousands) | |
| 6,721 | | |
| 6,719 | | |
| 6,720 | | |
| 6,716 | |
| | |
| | | |
| | | |
| | | |
| | |
| Weighted average number of ordinary shares used to compute | |
| | | |
| | | |
| | | |
| | |
| diluted net income (loss) per ordinary share (in thousands) | |
| 6,783 | | |
| 6,796 | | |
| 6,785 | | |
| 6,789 | |
| Eltek Ltd. |
| Consolidated Balance Sheets |
| U.S dollars in thousands |
| | |
September 30, | | |
December 31, | |
| | |
2026 | | |
2025 | |
| | |
| |
| Assets | |
| | | |
| | |
| | |
| | | |
| | |
| Current assets: | |
| | | |
| | |
| Cash and cash equivalents | |
| 9,131 | | |
| 2,481 | |
| Short-term bank deposits | |
| 1,248 | | |
| 9,643 | |
| Trade receivables (net of allowance for credit losses) | |
| 10,761 | | |
| 14,789 | |
| Inventories | |
| 10,197 | | |
| 11,154 | |
| Other accounts receivable and prepaid expenses | |
| 595 | | |
| 607 | |
| | |
| | | |
| | |
| Total current assets | |
| 31,932 | | |
| 38,674 | |
| | |
| | | |
| | |
| Long term assets: | |
| | | |
| | |
| Severance pay fund | |
| 74 | | |
| 65 | |
| Deferred tax assets, net | |
| 1,664 | | |
| 387 | |
| Operating lease right of use assets | |
| 12,102 | | |
| 6,272 | |
| Total long term assets | |
| 13,840 | | |
| 6,724 | |
| | |
| | | |
| | |
| Property and equipment, net | |
| 24,099 | | |
| 20,862 | |
| | |
| | | |
| | |
| Total Assets | |
| 69,871 | | |
| 66,260 | |
| | |
| | | |
| | |
| Liabilities and Shareholder's equity | |
| | | |
| | |
| | |
| | | |
| | |
| Current liabilities: | |
| | | |
| | |
| Trade payables | |
| 7,393 | | |
| 6,047 | |
| Other accounts payable and accrued expenses | |
| 6,825 | | |
| 6,565 | |
| Short-term operating lease liabilities | |
| 942 | | |
| 1,100 | |
| | |
| | | |
| | |
| Total current liabilities | |
| 15,160 | | |
| 13,712 | |
| | |
| | | |
| | |
| Long-term liabilities: | |
| | | |
| | |
| Accrued severance pay | |
| 824 | | |
| 515 | |
| Long-term operating lease liabilities | |
| 11,761 | | |
| 5,296 | |
| | |
| | | |
| | |
| Total long-term liabilities | |
| 12,585 | | |
| 5,811 | |
| | |
| | | |
| | |
| Shareholders' equity: | |
| | | |
| | |
| Ordinary shares of NIS 3.0 par value – Authorized: 10,000,000 shares at September 30, 2026 and December 31, 2025; Issued and outstanding: 6,722,393 shares at September 30, 2026 and 6,719,827 shares at December 31, 2025 | |
| 6,014 | | |
| 6,012 | |
| Foreign currency translation adjustments | |
| 7,877 | | |
| 6,111 | |
| Additional paid-in capital | |
| 36,056 | | |
| 35,681 | |
| Accumulated deficit | |
| (7,821 | ) | |
| (1,067 | ) |
| Total shareholders' equity | |
| 42,126 | | |
| 46,737 | |
| Total liabilities and shareholders' equity | |
| 69,871 | | |
| 66,260 | |
| Eltek Ltd. |
| Unaudited Non-GAAP EBITDA Reconciliations |
| U.S dollars in thousands |
| | |
Three months ended | | |
Nine months ended | |
| | |
September 30, | | |
September 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
| | |
| | |
| |
| GAAP net income (loss) | |
| (1,157 | ) | |
| (231 | ) | |
| (6,754 | ) | |
| 1,136 | |
| Add back items: | |
| | | |
| | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Financial income (expenses), net | |
| 295 | | |
| (287 | ) | |
| (497 | ) | |
| (795 | ) |
| Income tax expenses (tax benefit) | |
| (172 | ) | |
| (6 | ) | |
| (1,180 | ) | |
| 300 | |
| Depreciation | |
| 626 | | |
| 563 | | |
| 1,829 | | |
| 1,530 | |
| Non-GAAP EBITDA | |
| (998 | ) | |
| 613 | | |
| (5,608 | ) | |
| 3,761 | |
| Eltek Ltd. |
| Consolidated Statement of Cash flow |
| U.S dollars in thousands |
| | |
Three months ended | | |
Nine months ended | |
| | |
September 30, | | |
September 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
| | |
| | |
| | |
| |
| Cash flows from operating activities: | |
| | | |
| | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Net Income (loss) | |
| (1,157 | ) | |
| (231 | ) | |
| (6,754 | ) | |
| 1,136 | |
| Adjustments to reconcile net income to net cash flows | |
| | | |
| | | |
| | | |
| | |
| provided by operating activities: | |
| | | |
| | | |
| | | |
| | |
| Depreciation | |
| 626 | | |
| 563 | | |
| 1,829 | | |
| 1,530 | |
| Unrealized financing expenses (income), net | |
| 55 | | |
| 11 | | |
| (100 | ) | |
| 477 | |
| Share-based compensation | |
| 119 | | |
| 131 | | |
| 361 | | |
| 401 | |
| Decrease (increase) in deferred tax assets | |
| (211 | ) | |
| 27 | | |
| (1,275 | ) | |
| 229 | |
| | |
| 589 | | |
| 732 | | |
| 815 | | |
| 2,637 | |
| | |
| | | |
| | | |
| | | |
| | |
| Decrease (increase) in operating lease right-of-use assets | |
| 166 | | |
| 19 | | |
| 477 | | |
| 19 | |
| Decrease (increase) in trade receivables | |
| 603 | | |
| 626 | | |
| 4,691 | | |
| (1,107 | ) |
| Decrease (increase) in other receivables and prepaid expenses | |
| 350 | | |
| (10 | ) | |
| 38 | | |
| 237 | |
| Decrease (increase) in inventories | |
| (179 | ) | |
| 857 | | |
| 1,435 | | |
| (1,755 | ) |
| Increase (decrease) in trade payables | |
| (871 | ) | |
| (137 | ) | |
| (642 | ) | |
| (2,137 | ) |
| Increase (decrease) in other liabilities and accrued expenses | |
| 278 | | |
| 127 | | |
| (12 | ) | |
| 99 | |
| Increase (decrease) in employee severance benefits, net | |
| 265 | | |
| 19 | | |
| 285 | | |
| 65 | |
| | |
| 612 | | |
| 1,501 | | |
| 6,272 | | |
| (4,579 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Net cash provided by (used in) operating activities | |
| 44 | | |
| 2,002 | | |
| 333 | | |
| (806 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Cash flows from investing activities: | |
| | | |
| | | |
| | | |
| | |
| Purchase of fixed assets | |
| (750 | ) | |
| (1,386 | ) | |
| (2,423 | ) | |
| (4,266 | ) |
| Withdrawal of (investment in) short-term bank deposits, net | |
| 838 | | |
| - | | |
| 8,458 | | |
| 534 | |
| Net cash provided by (used in) investing activities | |
| 88 | | |
| (1,386 | ) | |
| 6,035 | | |
| (3,732 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Cash flows from financing activities: | |
| | | |
| | | |
| | | |
| | |
| Exercise of options | |
| 11 | | |
| 28 | | |
| 16 | | |
| 36 | |
| Dividend distribution | |
| - | | |
| - | | |
| - | | |
| (1,276 | ) |
| Issuance of shares, net | |
| - | | |
| - | | |
| - | | |
| - | |
| Net cash provided by (used in) financing activities | |
| 11 | | |
| 28 | | |
| 16 | | |
| (1,240 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Effect of translation adjustments | |
| (402 | ) | |
| (290 | ) | |
| 266 | | |
| 327 | |
| | |
| | | |
| | | |
| | | |
| | |
| Net increase (decrease) in cash and cash equivalents | |
| (259 | ) | |
| 354 | | |
| 6,650 | | |
| (5,451 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Cash and cash equivalents at the beginning of the period | |
| 9,390 | | |
| 1,770 | | |
| 2,481 | | |
| 7,575 | |
| | |
| | | |
| | | |
| | | |
| | |
| Cash and cash equivalents at the end of the period | |
| 9,131 | | |
| 2,124 | | |
| 9,131 | | |
| 2,124 | |